#in vitro diagnostics industry

[danamartinez17-blog]

🐣🤰🏽

Buscando mi positivo🐣

Hola, soy Daiana les quiero compartir un poco de mi camino en busqueda a un positivo, a un embarazo. Contarles un poco de estos años de busqueda hasta llegar hoy en dia a mi beta espera. - Tengo 31 años, junto con emi tomamos la decision de buscar un baby hace 3 años atras, muchas dudas, miedos y bueno nos lanzamos a comenzar sin saber que seria algo complicado para nosotros cuando es tan facil para el resto. No logrado el embarazo pasado los primeros tres y cinco meses acudí a mi ginecologa de cabecera para que me pueda orientar de lo que posiblemente podria estar pasando, y soy derivada a un medico especialista en fertilidad, ya que cierto tiempo sin un resultado positivo esto era lo que seguía. Una vez consultado mi cartilla medica hice recorridos por varios hospitales que me correspondían, pero aun asi seguian sin dar con un diagnostico ya que me mandaban a realizar tratamientos de baja complejidad, muchos analisis de sangre, ecografías a ambos, medicamentos para regular mi periodo y otras tantas cosas que la verdad no daban resultados mas que generarme angustia y creer que no era posible lograr embarazarme. Asi es como pasado un año de busqueda yendo y viniendo de hospitales a hospitales tuve la perdida de mi papa, llegado la pandemia fue muy traumatico en todo sentido, el tratamiento paso de ser prioridad en mi vida diaria a ser un ultimo plan deseado, la verdad mi cabeza estaba en vaya saber donde afrontando una lucha que no quisiera que fuera mia ni de nadie, pero me toco ser fuerte y encarar el dolor desde una fortaleza que gracias a la familia y los seres queridos pude tener todos los dias. La pandemia no solo se llevo a mi ser mas querido, tambien queriendo retomar el tratamiento mi medico me hizo hacer un freno y pensar que buscar un embarazo en estas situaciones no era lo mas indicado ya que podia infectarme saliendo de casa, y que las consultas via Whatsapp no llevarían a nada, es por eso que me quede con que no era el especialista que necesitaba, acudí nuevamente a mi cartilla medica y busque los centros medicos donde tenia convenio mi obra social y di con procrearte medicina reproductiva, luego de dos años ya calmado todo pandemia fuera, estragos la verdad que preferible dejarlos atras y con medicos que la verdad sentia como que no me quisieran ayudar, es chocante decirlo, pero asi lo senti, una vez dado con procrearte llego al consultorio de ramiro quintana, me da muchas ordenes analisis lo cual pasado tres meses volvi a verlo, porque despues de tres meses? porque hay un análisis de sangre llamado cariotipo de bangeo tarda dos meses en dar el resultado, es por eso que una vez recibido ese estudio volvimos a consultorio. Emi en este caso ya habia realizado sus analisis previos, en mi caso mis ovulos no lograban el tamaño adecuado, teniendo asi nuestro diagnostico, comenzamos el tratamiento.

[focusedmarketinsights]

Europe In-vitro Diagnostics (IVD) Market – Focused Insights 2024-2029

Europe in-vitro diagnostics (IVDs) market was valued at USD 27.75 billion in 2023 and is expected to reach USD 31.68 billion by 2029, growing at a CAGR of 2.23% during the forecast period. The market's growth is driven by increasing demand for in-vitro diagnostics solutions and an increase in the aging population with chronic infectious diseases. In addition, the increasing access to disease diagnosis and technology advancements in IVD solutions accelerate the adoption of IVD solutions.

https://www.focusreports.store/report/europe-in-vitro-diagnostics-market-focused-insights

The study considers a detailed scenario of the present in-vitro diagnostics market and its market dynamics for 2024−2029 in Europe. It thoroughly overviews several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent players operating in the market.

MARKET DEFINITION

In vitro diagnostics (IVDs) detect diseases, conditions, and infections in human blood or tissue samples. IVD medical devices include reagents, kits, instruments, equipment, or systems used to diagnose various diseases and health conditions or determine a patient's state of health.

MARKET DRIVERS

Growing Importance for Personalised Medicine: Personalised medicine is becoming increasingly important as scientists learn more about genetic makeup. The undeniable potential of digitization in healthcare is driven by this industry's capacity to recognize the worldwide demand for more advanced and personalized care. The new European Partnership for Personalised Medicine (EP PerMed) was officially launched in 2023. This will promote all areas and disciplines of precision medicine, facilitate innovation and transfer, and encourage its consolidation in health systems, allowing continuous improvement.

EUROPE IN-VITRO DIAGNOSTICS (IVDs) MARKET INSIGHTS

The reagents and consumables segment occupies a major market share of over 65% in the Europe in-vitro diagnostics (IVDs) market, owing to increasing focus on research in molecular biology and technological advancements in genomic sequencing. With the increasing adoption of in-vitro diagnostics solutions, the demand for reagents and consumables is increasing. Infectious diseases and pandemics such as COVID-19 significantly fuel the demand for reagents in diagnosis.

The hematology technology segment is growing significantly, with the fastest-growing CAGR during the forecast period. The growth of the hematology market is attributed to the increasing incidences of blood disorders and other diseases, rapid technological advances in hematology, and the emergence of high throughput hematology analyzers. As the demand for testing has surged in recent years, the laboratory's role in diagnosing and managing diseases has grown significantly.

The diabetic application segment showcases the highest growth rate in the Europe in-vitro diagnostics (IVDs) market. Rising health consciousness among the population and the demand for diabetes monitoring devices, coupled with the easy availability of advanced diabetes devices, are fostering market growth in this segment.

By end-user, the standard reference labs segment dominated the market share of the Europe in-vitro diagnostics (IVDs) market. In recent years, standard reference laboratories have rapidly expanded to offer numerous tests and deliver high market growth by adopting new technologies and product offerings, thus driving market growth.

REGIONAL ANALYSIS

Spain shows the highest growth rate, with a CAGR of 3% in Europe's in-vitro diagnostics (IVDs) market. The demand for IVD solutions has increased in the country due to the rising prevalence of chronic diseases associated with the aging population. In addition, awareness of early detection and diagnosis of various diseases, point-of-care IVD solutions, and advancing technologies in healthcare settings are major factors contributing to market growth.

[athenese-dx]

Celebrating 10 Years' Journey of Athenese-Dx Pvt. Ltd.

celebration #10years #athenesedx #Chennai #IVD #India #milestone

🎉 Celebrate a Decade of Innovation with Athenese-Dx! Join us in our 10th Anniversary Celebration as we continue to honor a decade of groundbreaking achievements at Athenese-Dx. This special video takes you on a journey through our most memorable moments, showcasing our commitment to excellence and innovation.

Highlights:

Milestone Moments: Relive our top achievements and how they've shaped the industry. From pioneering diagnostic technologies to life-changing breakthroughs, we've been at the forefront of medical advancements.Behind-the-Scenes: Get an exclusive look at the people and passion driving our success. Meet our brilliant scientists, dedicated researchers, and tireless support staff who have fueled our journey.Future Forward: Peek into the future as we unveil exciting plans for the next decade. Discover our vision for improving patient care, expanding global reach, and revolutionizing healthcare.

Thank You to Our Community: We extend our heartfelt gratitude to our customers, partners, and employees who have been part of our story. Your unwavering support and trust have propelled us forward.

Stay Connected: Don't miss out on any updates as we embark on the next chapter of our journey

diagnosticcenter #rapidtest #elisakit #biochemistry #ivdmanufacturing #clinicalchemistry #ivdinstrument #medicaldevices #reagents

Together, let's continue to redefine diagnostics and transform lives. Here's to the next ten years of excellence! 🥂 🎉 Cheers to many more amazing years! 🎉

ATHENESE-DX PRIVATE LIMITED Address: Module No. 407 & 408, 4th Floor, TICEL Bio Park II, No. 5, CSIR Road, Taramani, Chennai, Tamil Nadu - 600113, India

For Inquires - WhatsApp +917397238924 Click here to chat: https://wa.me/917397238924

For Reviews & News, go to https://www.athenesedx.com/

Follow us on WhatsApp Channel: https://whatsapp.com/channel/0029Va8M7HQChq6HfUBMLj0X

🌎 Visit our office - https://qr.page/g/5lZXERbP8Av

🤝 Subscribe - https://youtube.com/@athenesedx Our early diagnosis products for a better life. Thank you for your support.

🔔 For more videos, products, reviews ↷ YouTube ▶ https://youtube.com/@athenesedx

🌐 For more information ↷ Website ▶ https://athenesedx.com To Buy Athenese-Dx Products ▶ https://store.athenesedx.com

📱 Follow us on social media ↷ Facebook ▶ https://www.facebook.com/Athenese.Dx.Pvt.Ltd/ Instagram ▶ https://www.instagram.com/athenese_dx/ Pinterest ▶ https://www.pinterest.com/athenesedx/ X (Twitter) ▶ https://twitter.com/athenesedx Tumblr ▶ https://www.tumblr.com/athenese-dx LinkedIn ▶ https://www.linkedin.com/company/athenese-dx-private-limited/ Medium ▶ https://medium.com/@athenesedx01

[aishavass]

The remarkable growth rate of 6% is attributed to growing mergers & collaboration in this space coupled with growing government support in several...

[maryharrisk5]

Recent study published by Adroit Market Research on Global in vitro diagnostics (ivd) market evaluates the market demand and forecast based on various forecasting models.

[evonnebaker]

The remarkable growth rate of 6% is attributed to growing mergers & collaboration in this space coupled with growing government support in several developing economies to tackle growing healthcare needs. Molecular diagnostics have emerged as one of the leading and fastest-growing sectors of the IVD industry

[neha24blog]

In Vitro Diagnostics Market Segment Analysis By Product, Technology, Application, End-Use, Test Location, Region And Forecast Till  2030 : Grand View Research Inc.

In Vitro Diagnostics Market Segment Analysis By Product, Technology, Application, End-Use, Test Location, Region And Forecast Till  2030 : Grand View Research Inc.

San Francisco, 24 Nov 2022: The Report In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Reagents, Services), By Test Location (PoC, Homecare), By End-use (Hospitals, Laboratory), By Application, By Technology, And Segment Forecasts, 2022 – 2030 The global in vitro diagnostics market size is expected to reach USD 113.38 billion by 2030, according to a new report by…

[tbrcresearchreport]

The Business Research Company offers in vitro diagnostics ivd quality control market research report 2023 with industry size, share, segments and market growth

[shital1998]

TOP 10 COMPANIES IN LATIN AMERICA IN VITRO DIAGNOSTICS (IVD) MARKET

[aishavass]

The remarkable growth rate of 6% is attributed to growing mergers & collaboration in this space coupled with growing government support in several...

[esglatestmarketnews]

In Vitro Diagnostics Quality Control Market Research Report and Industry Analysis By 2026

The global IVD quality control market size is expected to reach USD 1.24 billion by 2026, according to a new report by Grand View Research, Inc. The market is projected to witness a CAGR of 4.1% over the forecast period. Continually evolving technology-oriented changes in the diagnostics field and growing need to ensure patient safety necessitate the implementation of quality assurance programs in various medical disciplines including radiology and Point-of-Care (PoC) devices. Patients rely on self-testing IVD devices for long-term disease management and hence it is important for such devices to be checked, in terms of result reproducibility and validity, to guarantee patient safety.

Rising number of certified clinical laboratories offering dependable IVD-based diagnostic services directly correlates with increased patient confidence, thus driving the market. In addition to quality assessments, amendments to the regulatory framework are made intermittently to enhance the existing standards with the main objective of safeguarding qualitative superiority of the diagnostic services. In May 2016, the European Union passed an agreement to update the pre-existing regulations pertaining to IVD devices, wherein the updates were in concern with raising the patient safety levels, particularly for disabled persons. The presence of third-party agencies for independent assessment of the IVD devices is expected to elevate the current safety standards, which will drive the In Vitro Diagnostics (IVD) Quality Control market further.

Further key findings from the study suggest:

• In 2018, the clinical chemistry was the second-largest application segment of the global IVD market, in terms of market share

• Demand for preventive medicine and rapid transformation of clinical laboratories into highly automated and efficient businesses are some of the factors for the segment’s growth

• Molecular diagnostics is projected to be the fastest-growing segment due to increasing technical complexity of molecular diagnostic testing and need for quality evaluation to ensure standards

• These tests are of prime importance as the outcomes enable healthcare practitioners make critical treatment decisions

• Hospitals was the largest segment in 2018 due to the presence of advanced technology-based devices like Next Generation Sequencing (NGS) and microarrays, and rising applications of the optimized quality-control procedures

• North America was the dominant regional market in 2018 due to the presence of over 150,000 registered diagnostics labs and is likely to maintain the dominance throughout the forecast years

• Siemens Healthcare GmbH; Roche Diagnostics; Alere, Inc.; Abbott Laboratories, Inc.; Qiagen N.V.; Bio-Rad Laboratories, Inc.; Quidel Corp.; Becton, Dickinson and Company; bioMerieux, Inc.; Sysmex Corp.; Sero AS; and Thermo Fisher Scientific, Inc. are some of the key companies in the global market

The global In Vitro Diagnostics (IVD) and IVD quality control market combines to account for USD 112.79 billion in revenue in 2021, which is expected to reach USD 114.73 billion by 2030, growing at a cumulative rate of 0.2% over the forecast period. 

In Vitro Diagnostics Quality Control Market Segmentation:

Grand View Research has segmented the global IVD quality control market on the basis of application, type, end use, and region:

IVD Quality Control Application Outlook (Revenue, USD Million, 2014 – 2026)

• Immunochemistry

• Hematology

• Clinical Chemistry

• Molecular Diagnostics

• Coagulation

• Microbiology

• Others

IVD Quality Control Type Outlook (Revenue, USD Million, 2014 – 2026)

• Quality Control

Quality Controls, by Type

Plasma-based Control

Serum-based Control

Whole Blood-based Control

Others

Quality Controls, by Application

Immunochemistry

Hematology

Clinical Chemistry

Molecular Diagnostics

Coagulation

Microbiology

Others

• Quality Assurance Services

Immunochemistry

Hematology

Clinical Chemistry

Molecular Diagnostics

Coagulation

Microbiology

Others

• Data Management

Clinical Chemistry

Immunochemistry

Hematology

Molecular Diagnostics

Coagulation

Microbiology

Others

IVD Quality Control End Use Outlook (Revenue, USD Million, 2014 – 2026)

• Hospitals

• Laboratories

• Home-care

• Others

IVD Quality Control Regional Outlook (Revenue, USD Million, 2014 – 2026)

• North America

U.S.

Canada

• Europe

U.K.

Germany

France

Spain

Italy

Russia

• Asia Pacific

Japan

China

India

South Korea

Singapore

Australia

• Latin America

Brazil

Argentina

• Middle East & Africa

South Africa

UAE

Saudi Arabia

Order a free sample of this Intelligence study @ https://www.grandviewresearch.com/sector-report/in-vitro-diagnostics-ivd-quality-control-industry-data-book/request/rs1 

[joeypetter]

Global In Vitro Diagnostics (IVD) Market Report 2022| Research Analysis with Trends, Segmentation, Share and Forecast by 2030| By R&I

The report is titled as ‘In Vitro Diagnostics Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the In Vitro Diagnostics market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market. In Vitro Diagnostics market is expected to grow with significant rate in the near future.

The global In Vitro Diagnostics (IVD) market in 2020 is estimated for more than US$ 70,561.9 Mn and expected to reach a value of US$ 1,03,310.9 Mn by 2028 with a significant CAGR of 4.9%.

Request a Sample Copy of this Report @: https://reportsandinsights.com/sample-request/1256

In Vitro Diagnostics Market Dynamics

In-vitro diagnostics are tests performed in laboratories on biological samples such as blood, urine, tissue, etc. In vitro diagnostic are not only used for diagnosis but also provides useful information on monitoring of disease and treatment. Two-thirds of today’s clinical diagnoses involve in vitro diagnostics, hence are referred to as the backbone of healthcare.

In-vitro diagnostics market has witnessed substantial growth in last decade owing to technological advancements in testing methods as well as in analyzer instruments. According to the EPRS report, there are over 40,000 different IVD products available in the European market and per capita annual spending on IVD is approximately US$ 26. In-vitro diagnostics help to reduce the healthcare cost by making treatments more efficient and precise.

Evolving regulations for in-vitro diagnostics is the major driving force for market growth over the forecast period. For instance, regulation of medical devices in the European Union (EU) is undergoing a significant transformation with expanding the scope for in vitro diagnostics, which is expected to impact the increased product approvals for IVD in the region. Significant progress in point-of-care testing is another factor driving the growth of the global in-vitro diagnostics market. Introduction of molecular based assays and identification of range of biomarkers has opened up huge new opportunity for growth of global in-vitro diagnostics market.

MMC Overview on In Vitro Diagnostics Market Report

The non-identical approach of Reports and Insights stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.

A research report on the In Vitro Diagnostics market by Reports and Insights is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market.

Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.

Wish to Know More About the Study? Click here to get a Report Description: https://reportsandinsights.com/pressrelease/global-in-vitro-diagnostics-market

In Vitro Diagnostics Market Segmentation

The global in vitro diagnostics market is segmented on the basis of product type, technology, end user and region. On the basis of product type, in vitro diagnostics market is segmented as reagents and kits, analyze, and consumables. Based on technology, global market is segmented as immunochemistry, molecular diagnostics, hematology, point-of-care diagnostics, tissue diagnostics and clinical chemistry. On the basis of end user, global in vitro diagnostics market is segmented into hospitals, diagnostic centers, clinics, home care settings and others.

By Products & Services

Reagents & Kits

Instruments

Fully Automated Instruments

Semi-Automated Instruments

Other Instruments

Data Management Software

Services

By Technology

mmunoassay/Immunochemistry

Enzyme-Linked Immunosorbent Assay

hemiluminescence Immunoassays

Fluorescence Immunoassays

Colorimetric Immunoassays

Radioimmunoassay

Rapid Test

Western Blotting

Enzyme-Linked Immunospot Assays

Clinical Chemistry

Basic Metabolic Panel

Electrolyte Panel

Liver Panel

Lipid Profile

Renal Profile

Thyroid Function Panel

Specialty Chemical Tests

Molecular Diagnostics

Polymerase Chain Reaction

Isothermal Nucleic Acid Amplification Technology

Microarray

Hybridization

DNA Sequencing & Next-Generation Sequencing

Other Mdx Technologies

Microbiology

Hematology

Coagulation and Hemostasis

Urinalysis

Other IVD Technologies

By Application

 Infectious Diseases

 Diabetes

 Oncology

 Cardiology

 Autoimmune Diseases

 Nephrology

 Drug Testing/Pharmacogenomics

 HIV/Aids

 Other Applications

By End User

Hospitals

Laboratories

Large/Reference Laboratories

Medium-Sized Laboratories

Small Laboratories

Point-Of-Care Testing

Patient Self-Testing

Academic Institutes

Other End Users

By Region

 North America

 Latin America

 Europe

 Asia Pacific

 Middle East

 Africa

In Vitro Diagnostics Market Competitive Landscape

Global market for in vitro diagnostics is dominated by Abbott Laboratories, Merck KGaG, F. Hoffman-La Roche AG, Becton Dickinson & Company, Danaher Corporation, Thermo Fisher Scientific Inc., Qiagen N.V., Diasorin S.P.A., biomerieux SA, Alere Inc., Bayer AG, Bio-Rad Laboratories Inc., Sysmex Corporation, etc. to name a few.

To view Top Players, Segmentation and other Statistics of In Vitro Diagnostics (IVD) Industry, Get Sample Report @: https://reportsandinsights.com/sample-request/1256

About Reports and Insights:

Reports and Insights is one of the leading market research companies which offers syndicate and consulting research around the globe. At Reports and Insights, we adhere to the client needs and regularly ponder to bring out more valuable and real outcomes for our customers. We are equipped with strategically enhanced group of researchers and analysts that redefines and stabilizes the business polarity in different categorical dimensions of the market.

Contact Us:

Neil Jonathan

1820 Avenue M, Brooklyn

NY 11230, United States

+1-(718) 312-8686

Find Us on LinkedIn: www.linkedin.com/company/report-and-insights/

View Latest Market Updates At: https://marketsresearchanalytics.com

[neha24blog]

Europe In Vitro Diagnostics Market Focusing On The Basis Of Product, Technology, Application, Test Location, Region And Forecasts To 2025    : Grand View Research Inc.

San Francisco, 23 May 2023: The Report Europe In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents, Services), By Technique (Immunology, Hematology, Clinical Chemistry, Coagulation, Microbiology, Molecular Diagnostics) By Application By End-use, And Segment Forecasts To 2024 The Europe IVD market is expected to reach over USD 15.5 billion by 2024…

[rohit890]

In Vitro Diagnostics (IVD) Quality Control Market Analysis, Demand & Forecast to 2020 – Bio-Rad Laboratories, Inc. (US), Randox Laboratories Ltd. (UK)

Market Overview

The global in vitro diagnostics quality control market was valued at USD 1.5 billion in 2021 and it is anticipated to grow further up to USD 2.2 billion by 2031, at a CAGR of 3.7% during the forecast period.

The effectiveness of in vitro diagnostic tests, including those for pathogen identification using in vitro nucleic acid testing, healthcare-associated illnesses (HAIs) such as pneumonia, urinary tract infections, and others, is assessed using IVD quality controls. These products primarily concentrate on defect detection, quality control, and validation panels like the Blood Culture (BCID) Control Panel, Human Papillomavirus (HPV) Control Panel, and others to support in the implementation and monitoring of the performance of clinical and research laboratories, blood diagnostic centers, and IVD manufacturers.

View Detailed Report Description: https://www.globalinsightservices.com/reports/in-vitro-diagnostics-ivd-quality-control-market/

Market Dynamics

As the burden of various diseases increases globally, so has the number of laboratory tests. The number of laboratories in both the public and private sectors has increased in response to this need. With the start of the COVID-19 pandemic in December 2019, the demand for diagnostic tests has skyrocketed. Many government organizations have established new laboratories in response to this epidemic and to increase laboratory testing capacity. The majority of nations need clinical laboratories to get regulatory body accreditation before performing diagnostic tests. Additionally, accreditation to ISO 15189:2012 and other comparable standards is turning into a requirement in many nations. Authorities assess a laboratory’s competency and quality system during the accreditation process using predetermined standards. While some European nations, including Belgium, France, Hungary, Ireland, and Lithuania, require accreditation for a variety of laboratory tests, others, like Finland, the Netherlands, Sweden, Switzerland, and the UK, have practically finished the process.

It costs a lot of money to set up a QC process in a clinical laboratory. Additionally, laboratories must keep a specialized staff on hand to oversee the QC system. Moreover, regardless of the number of tests conducted, QC procedures are expensive. As a result, QC methods are particularly expensive to adopt for clinical laboratories that perform few diagnostic tests. This is predicted to lead to a lesser adoption of QC procedures, along with budgetary restrictions in many hospitals and laboratories in developed and emerging nations.

Get Free Sample Copy of This Report: https://www.globalinsightservices.com/request-sample/GIS10301

The key players studied in the global in vitro diagnostic quality control market are Bio-Rad Laboratories, Inc. (US), Randox Laboratories Ltd. (UK), Thermo Fisher Scientific, Inc. (US), LGC Limited (UK), Abbott Laboratories (US), Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Fortress Diagnostics (UK), SERO AS (US), Sysmex Corporation (Japan), Ortho-Clinical Diagnostics (US), and Helena Laboratories Corporation (US) among others.

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC

16192, Coastal Highway, Lewes DE 19958

E-mail: info@globalinsightservices.com

Phone: +1–833–761–1700

[blueweave]

 United States In-Vitro Diagnostics (IVD) Market size at USD 33.50 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects United States In-Vitro Diagnostics (IVD) Market size to expand at a CAGR of 5.70% reaching a value of USD 49.10 billion by 2030. The growing elderly population and the increasing incidence of both communicable and non-communicable diseases are key drivers of United States in-vitro diagnostics (IVD) market. The number of point-of-care tests is also rising along with the use of automation in labs and automated equipment, which is expected to provide United States in-vitro diagnostics (IVD) market enormous potential for expansion over the period in analysis.

Opportunity - Rising adoption of automation in IVD labs

The increasing adoption of automated instruments and automation in laboratories is anticipated to present lucrative growth opportunities for United States In-Vitro Diagnostics (IVD) Market. Automated instruments provide several benefits, such as higher performance levels, enhanced productivity, data accuracy, and meeting safety protocols. As a result, many industry players are developing and launching automated instruments that offer higher efficiency and effectiveness in diagnostic tests. The increasing test volumes and shortage of skilled lab personnel are anticipated to boost automation in laboratories, thus, in turn, driving the growth of United States In-Vitro Diagnostics (IVD) Market.

Sample Request @ https://www.blueweaveconsulting.com/report/united-states-in-vitro-diagnostics-market/report-sample